Evaluate Safety and Efficacy of a Single Treatment Cycle of EB-001 in Subjects With Glabellar Frown Lines
NCT02939326 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 42
Last updated 2019-02-15
Summary
To evaluate the safety and efficacy of EB-001 compared to placebo in subjects with glabellar frown lines (GL).
Conditions
- Glabellar Frown Lines (GL)
Interventions
- DRUG
-
EB-001 injection
- DRUG
-
Placebo injection
Sponsors & Collaborators
-
Bonti, Inc.
lead INDUSTRY
Principal Investigators
-
Earvin Liang · Bonti, Inc.
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-12-31
- Primary Completion
- 2017-07-12
- Completion
- 2017-07-12
Countries
- United States
Study Locations
More Related Trials
-
The Treatment of Glabellar Frown Lines
NCT02096081 ·Status: COMPLETED ·Phase: PHASE4
-
Study of EB-001 in Facial Scar Reduction
NCT03346902 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of DaxibotulinumtoxinA for Injection to Treat Moderate to Severe Glabellar Lines
NCT03014622 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of DaxibotulinumtoxinA for Injection to Treat Moderate to Severe Glabellar Lines
NCT03014635 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of a New Dilution and Injection Volume of AbobotulinumtoxinA for the Treatment of Glabellar Lines
NCT03960957 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase II Study to Evaluate the Efficacy and Safety of MBA-P01 in Subjects With Moderate to Severe Glabellar Lines
NCT05217355 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of NT 201 in the Treatment of Lateral Periorbital Wrinkles
NCT00541723 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase I Study of KB301, a Replication-Incompetent, Non-Integrating Vector Expressing Human Type III Collagen (COL3) for the Treatment of Superficial Skin Depressions
NCT04540900 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Patient Satisfaction Study of BOTOX® Cosmetic in the Treatment of Moderate to Severe Frown Lines
NCT01391312 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy Study of the Simultaneous Treatment of Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines and Lateral Canthal Lines) in Subjects With Moderate to Severe Upper Facial Lines
NCT04594213 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase 3 Clinical Study to Evaluate the Efficacy and Safety of Botulinum Toxin Type A for Injection (CU-20101)
NCT06585696 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of NT 201 (IncobotulinumtoxinA [Xeomin]) in the Treatment of Glabellar Frown Lines
NCT00512135 ·Status: COMPLETED ·Phase: PHASE3
-
IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Glabellar Frown Lines
NCT00770211 ·Status: COMPLETED ·Phase: PHASE3
-
MT10109L in the Treatment of Lateral Canthal Lines With or Without Concurrent Treatment of Glabellar Lines
NCT03732833 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of NT 201 in the Treatment of Enlarged Pores and Excessive Sebum Production in the Face
NCT05784363 ·Status: COMPLETED ·Phase: PHASE1
-
Microbotox for Lower Face Rejuvenation
NCT03189082 ·Status: COMPLETED ·Phase: NA
-
Study to Compare 2 Botulinum Type A Toxins in the Treatment of Glabellar Frown Lines
NCT04763265 ·Status: COMPLETED ·Phase: PHASE2
-
A Long-Term Safety Study of Repeat Treatment With PurTox® for Frown Lines Between the Eyebrows
NCT00752258 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Efficacy and Safety of MBA-P01 in Subjects With Glabellar Lines
NCT05059587 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate AGN-151586 Intramuscular Injections in Adult Participants for Treatment of Glabellar Lines
NCT06308198 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy Study of Dysport RU and Glabellar Lines
NCT01333397 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Trial to Evaluate the Efficacy and Safety of MBA-P01 in Treatment of Lateral Canthal Lines
NCT04143854 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Botulinum Toxin Type A for Moderate to Severe Crow's Feet Lines
NCT01940991 ·Status: COMPLETED ·Phase: PHASE2
-
IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Glabellar Frown Lines No. 2
NCT00770029 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy Study of the Simultaneous Treatment of Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines and Crows Feet) in Subjects With Moderate to Severe Upper Facial Lines
NCT04622254 ·Status: COMPLETED ·Phase: PHASE3